➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204756

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 204756 describes METOCLOPRAMIDE, which is a drug marketed by Emcure Pharms Ltd, Bedford, Fresenius Kabi Usa, Hospira, Lyphomed, Norbrook, Smith And Nephew, Teva Pharms Usa, Actavis Mid Atlantic, Ani Pharms, Lannett Co Inc, Morton Grove, Paco, Pharm Assoc, Roxane, Teva, Vistapharm, Wockhardt Bio Ag, Novel Labs Inc, Clonmel, Halsey, Impax Labs Inc, Interpharm, Ipca Labs Ltd, Mutual Pharm, Northstar Hlthcare, Par Pharm, Par Pharm Inc, Sandoz, Schering, Sun Pharm Industries, Superpharm, Usl Pharma, Vintage Pharms, Watson Labs, and Yaopharma Co Ltd, and is included in fifty-five NDAs. It is available from one supplier. Additional details are available on the METOCLOPRAMIDE profile page.

The generic ingredient in METOCLOPRAMIDE is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
Summary for 204756
Applicant:Emcure Pharms Ltd
Ingredient:metoclopramide hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 204756
Mechanism of ActionDopamine D2 Antagonists
Medical Subject Heading (MeSH) Categories for 204756
Suppliers and Packaging for NDA: 204756
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METOCLOPRAMIDE metoclopramide hydrochloride INJECTABLE;INJECTION 204756 ANDA Heritage Pharmaceuticals Inc. 23155-240 23155-240-41 25 VIAL in 1 CARTON (23155-240-41) > 2 mL in 1 VIAL (23155-240-31)
METOCLOPRAMIDE metoclopramide hydrochloride INJECTABLE;INJECTION 204756 ANDA Heritage Pharmaceuticals Inc. 23155-240 23155-240-42 25 VIAL in 1 CARTON (23155-240-42) > 10 mL in 1 VIAL (23155-240-32)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength EQ 5MG BASE/ML
Approval Date:Dec 20, 2013TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.